Ubi-Q Capsule 60mgIndicationsIt is indicated for Co-enzyme Q10 deficiency and mitochondrial disorders. It is also used in congestive heart failure, myocardial infarction, high blood pressure (hypertension) in combination with other medications, preventing migraine headache, parkinson's disease, improving the immune system, infertility in men and muscular dystrophy.PharmacologyCo-enzyme Q10 is a vitamin-like substance found throughout the body especially in the heart, liver, kidney and pancreas. It is required for the proper function of many organs and chemical reactions in the body. It helps to provide energy to cells. It has antioxidant activity...
Floriz 1000 mcg TabletDescription:
Biotin is an essential vitamin that is also
known as vitamin H. It is involved in vital
physiological function like fatty acid synthesis,
amino acid catabolism and gluconeogenesis.
It acts as a cofactor in the enzymatic
carboxylation of pyruvate and acetyl-CoA.
Biotin influences the growth and
differentiation of epidermal cells and is
therefore important for the formation and
renewal of the skin, hair and nails. It functions
as a coenzyme for mitochondrial carboxylases
in hair roots and improves the keratin
structure. Biotin deficiency may result in hair
loss and a variety of systemic symptoms such
as dermatitis, and aciduria. Biotin is one of the
most prescribed nutritional supplements for
any kind of hair loss.Indications and Uses: • Hair loss • Weak, brittle, splitting or soft nails • Eczema & dermatitis Recommended Dietary Allowance:Life-stage group RDA (mcg/day)Infants (months)0–6 57–12 6Children (years)1–3 84–8 12Males and females (years)9–13 2014–18 25≥19 30Pregnancy 30Lactation 35 Dosage and Administration:Biotin dose varies depending on diseasecondition and age group. Generally 1-3tablets per day or as advised by the physician.In children biotin deficiency affects between 1week and 2 years of age and usually exhibitseizures, hypotonia, developmental delay,ataxia, hyperventilation and coma. In this case5-10 tablets daily, crushed and mixed withwater or any kind of fruit juice or as advisedby the physician. Contraindications:Contraindicated in patients with knownhypersensitivity to any of the ingredients. Pregnancy and Lactation:Sufficient clinical data is not available to use inpregnant women and lactating mother.Side Effects:Well tolerated in recommended dose.No biotin toxicity has been reported inindividuals supplemented with as much as200 mg orally or 20mg intravenously per day. Drug Interactions:
There are indications that anticonvulsant
drugs lower the plasma level of biotin.
Antibiotic use may decrease the biotin
contribution to the body made by the
microflora of the large intestine. Excessive
consumption of raw egg whites interferes
with biotin absorptionPharmaceutical Precautions:
Store in a cool and dry place, away from light
and moisture.Keep out of reach of children. ..
Empagliflozin10 mgRadiant Pharmaceuticals Ltd.What is Jardian®?Jardian® is a preparation of Empagliflozin. Empagliflozin is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults. It is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine.What is the indications of Jardian®?Jardian is indicated as an adjunct to diet and exercise for the treatment of type-2 diabetes. It can be given alone or in combination with other oral antidiabetic agents. It is also indicated for reduction in cardiovascular risk in type-2 diabetic patients.How Jardian® works in our body?Empagliflozin is an SGLT2 inhibitor, a drug class which helps to stop sodium-glucose transports reabsorbing glucose that have been filtered out of the blood by the kidneys, back into the blood. It allows a significant amount of sugar to be removed through urination. The SGLT2 transports are responsible for reabsorbing 90 per cent of the glucose that is reabsorbed into the blood.Who is Jardian® suitable for?Jardian® is recommended as a treatment for type 2 diabetes under the following conditions:When diet and exercise do not provide adequate glycemic controlWhen metformin is not appropriate due to patient intoleranceIt is the only oral anti diabetic agent approved to reduce the risk of CV Death in Type 2 diabetes patients with cardiovascular risk.Jardian® is also recommended alongside metformin if a patient is at significant risk of hypoglycemia or cannot take a sulfonylurea. It can also be taken with either metformin or a sulfonylurea.Who should not take Jardian ® ?One should not take Jardian® if he or she has:Type 1 diabetesSevere kidney problemsBefore taking Jardian®, please inform your doctor :Have kidney problemsAre pregnant, or planning to become pregnantAre breastfeeding, or planning to breastfeedHave liver problemsHave low blood pressureTake blood pressure medicationHave high cholesterol levelsHave a history of urinary tract infectionsHow Jardian® is supplied?Jardian® 10 Tablet: Box containing 20 tablets in blister strips. Each film coated tablet contains Empagliflozin INN 10 mg.Jardian® 25 Tablet: Box containing 10 tablets in blister strips. Each film coated tablet contains Empagliflozin INN 25 mg. Jardian Prescribing Information..
2 gm sachet: ৳ 140.00 (60's pack: ৳ 8,400.00)IndicationsMesalazine is indicated forTreatment of mild to moderately active Ulcerative Colitis & & Crohn’s DiseaseMaintenance of remission of Ulcerative ColitisMaintenance of remission of Crohn’s diseasePharmacologyThe mechanism of action of Mesalamine is unknown, but appears to be topical rather than systemic. Mucosal production of Arachidonic Acid metabolites, both through the cyclooxygenase pathways, that is, prostanoids, and through the lipoxygenase pathways, that is, leukotrienes and hydroxyeicosatetraenoic acids, is increased in patients with chronic infammatory bowel disease. Mesalamine diminishes infammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon.DosageUlcerative colitis-Adults:Active disease: Individual dosage, up to 4 gm mesalazine once daily or divided into 2-4 doses.Maintenance treatment: Individual dosage. Recommended dosage, 2 gm mesalazine once daily.Pediatrics: The safety and efficacy in children below 6 years of age have not been established. There is only limited documentation for an effect in children (age 6-18 years).Children 6 years of age and older:Active disease: To be determined individually, starting with 30-50 mg/kg/day in divided doses. Maximum dose: 75 mg/kg/day in divided doses. The total dose should not exceed 4 g/day (maximum adult dose).Maintenance treatment: To be determined individually, starting with 15-30 mg/kg/day in divided doses. The total dose should not exceed 2 g/day (recommended adult dose).It is generally recommended that half the adult dose may be given to children up to a body weight of 40 kg; and the normal adult dose to those above 40 kg.* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'AdministrationThe granules must not be chewed. The contents of the sachet should be emptied onto the tongue and washed down with some water or orange juice. Alternatively, the entire content of the sachet can be taken with yogurt and consumed immediately.* চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'InteractionConcurrent use of other known nephrotoxic agents such as NSAIDs and Azathioprine may increase the risk of renal reactions.ContraindicationsHypersensitivity to salicylates or to any other component of the formulation.Side EffectsThe commonly reported adverse events are headache, nausea, dizziness, asthenia, dyspepsia, vomiting, pruritus etc.Pregnancy & LactationIt should be given in pregnancy only if the potential beneft justifes the potential risk to the fetus. Caution is advised when it is administered to a nursing mother.Precautions & WarningsPatients with pyloric stenosis may have prolonged gastric retention of Mesalamine tablets which could delay release of Mesalamine in the colon. Renal impairment, including minimal change nephropathy and acute and chronic interstitial nephritis has been reported in patients taking Mesalamine. Therefore, caution should be exercised when using Mesalamine in patients with known renal dysfunction or history of renal disease. Patients should have renal function monitored, prior to treatment start and then it should be monitored periodically during treatment. There have been reports of hepatic failure in patients with pre-existing liver disease who have been administered Mesalamine. Caution should be exercised when administering Mesalamine to patients with liver impairment.Use in Special PopulationsGeriatrics: Patients who are 65 years or older, caution should be taken to closely monitor blood cell counts during Mesalamine therapy.Elderly: Because elderly patients are more likely to have decreased renal function, care should be taken when prescribing this drug therapy. It is recommended that all patients have an evaluation of renal function prior to initiation of Mesalamine tablets. Monitor blood cell counts during drug therapy.Paediatric: Safety and effectiveness have not been established.Overdose EffectsThere is no specifc antidote for Mesalamine overdose. Treatment for suspected acute severe toxicity should be symptomatic and supportive. This may include prevention of further gastrointestinal tract absorption, correction of fuid electrolyte imbalance and maintenance of adequate renal function. This is a pH dependent delayed-release product and this factor should be considered when treating a suspected over dose.Therapeutic ClassAminosalicylatesStorage ConditionsStore below 30 0 C. Protect from light and moisture. Keep all medicines out of the reach of children...